Demonstrating the Manufacture of Human CAR-T Cells in an Automated Stirred-Tank Bioreactor.

CAR-T cells bioprocessing immunotherapy manufacture stirred-tank bioreactor

Journal

Biotechnology journal
ISSN: 1860-7314
Titre abrégé: Biotechnol J
Pays: Germany
ID NLM: 101265833

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 15 04 2020
revised: 01 06 2020
pubmed: 28 6 2020
medline: 16 3 2021
entrez: 28 6 2020
Statut: ppublish

Résumé

Chimeric antigen receptor T-cell (CAR-T) therapies have proven clinical efficacy for the treatment of hematological malignancies. However, CAR-T cell therapies are prohibitively expensive to manufacture. The authors demonstrate the manufacture of human CAR-T cells from multiple donors in an automated stirred-tank bioreactor. The authors successfully produced functional human CAR-T cells from multiple donors under dynamic conditions in a stirred-tank bioreactor, resulting in overall cell yields which were significantly better than in static T-flask culture. At agitation speeds of 200 rpm and greater (up to 500 rpm), the CAR-T cells are able to proliferate effectively, reaching viable cell densities of >5 × 10

Identifiants

pubmed: 32592336
doi: 10.1002/biot.202000177
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2000177

Informations de copyright

© 2020 The Authors. Biotechnology Journal published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

T. I. Panagopoulou, Q. A. Rafiq, Biotechnol. Adv. 2019, 37, 107411.
P. Vormittag, R. Gunn, S. Ghorashian, F. S. Veraitch, Curr. Opin. Biotechnol. 2018, 53, 164.
S. Depil, P. Duchateau, S. Grupp, G. Mufti, L. Poirot, Nat. Rev. Drug Discovery. 2020, 19, 185.
Q. A. Rafiq, C. J. Hewitt, Pharm. Bioprocess. 2015, 3, 97.
A. W. Nienow, Cytotechnology 2006, 50, 9.
A. W. Nienow, B. Isailovic, T. Barrett, Bioprocess Int. 2016, 14, 12.
A. W. Nienow, K. Coopman, T. R. Heathman, Q. A. Rafiq, C. J. Hewitt, Stem Cell Manufacturing, Elsevier, New York 2016, p. 43.
R. P. Harrison, S. Ruck, Q. A. Rafiq, N. Medcalf, Biotechnol. Adv. 2018, 36, 345.
Q. A. Rafiq, M. P. Hanga, T. R. Heathman, K. Coopman, A. W. Nienow, D. J. Williams, C. J. Hewitt, Biotechnol. Bioeng. 2017, 114, 2253.
E. Costariol, M. Rotondi, A. Amini, C. J. Hewitt, A. W. Nienow, T. R. Heathman, M. Micheletti, Q. A. Rafiq, Biotechnol. Bioeng. 2019, 116, 2488.
A. W. Nienow, in Mixing in the Process Industries, 2nd ed. (Eds: N. Harnby, M. Edwards, A. Nienow), Butterworth Heinemann, London 1997, p. 394.
C. K. van den Bos, R. Keefe, C. Schirmaier, M. McCaman, in Disposable Bioreactors II (Ed: D. E. Eibl), Springer, Berlin, Heidelberg 2014, p. 61.
A. Gabriele, A. W. Nienow, M. Simmons, Chem. Eng. Sci. 2009, 64, 126.
A. W. Nienow, C. J. Hewitt, T. R. Heathman, V. A. Glyn, G. N. Fonte, M. P. Hanga, K. Coopman, Q. A. Rafiq, Biochem. Eng. J. 2016, 108, 24.
G. J. van der Windt, E. L. Pearce, Immunol. Rev. 2012, 249, 27.
V. Konakovsky, C. Clemens, M. M. Müller, J. Bechmann, M. Berger, S. Schlatter, C. Herwig, Bioengineering 2016, 3, 5.
W. M. Miller, H. Blanch, C. Wilke, Biotechnol. Bioeng. 2000, 67, 853.
C. J. Turtle, L. A Hanafi, C. Berger, T. A. Gooley, S. Cherian, M. Hudecek, D. Sommermeyer, K. Melville, B. Pender, T. M. Budiarto, J. Clin. Invest. 2016, 126, 2123.
E. Cha, L. Graham, M. H. Manjili, H. D. Bear, Breast Cancer Res. Treat. 2010, 122, 359.
D. Sommermeyer, M. Hudecek, P. L. Kosasih, T. Gogishvili, D. G. Maloney, C. J. Turtle, S. R. Riddell, Leukemia 2016, 30, 492.
N. Singh, J. Perazzelli, S. A. Grupp, D. M. Barrett, Sci. Transl. Med. 2016, 8, 320ra3.
M. Sabatino, J. Hu, M. Sommariva, S. Gautam, V. Fellowes, J. D. Hocker, S. Dougherty, H. Qin, C. A. Klebanoff, T. J. Fry, Blood 2016, 128, 519.
J. N. Kochenderfer, M. E. Dudley, S. A. Feldman, W. H. Wilson, D. E. Spaner, I. Maric, M. Stetler-Stevenson, G. Q. Phan, M. S. Hughes, R. M. Sherry, J. C. Yang, U. S. Kammula, L. Devillier, R. Carpenter, D. A. Nathan, R. A. Morgan, C. Laurencot, S. A. Rosenberg, Blood 2012, 119, 2709.
X. Wang, I. Rivière, Cancer Gene Ther. 2015, 22, 85.
R. P. Somerville, L. Devillier, M. R. Parkhurst, S. A. Rosenberg, M. E. Dudley, J. Transl. Med. 2012, 10, 69.
D. Hollyman, J. Stefanski, M. Przybylowski, S. Bartido, O. Borquez-Ojeda, C. Taylor, R. Yeh, V. Capacio, M. Olszewska, J. Hosey, J. Immunother. 2009, 32, 169.
W. Zhang, K. R. Jordan, B. Schulte, E. Purev, Drug Des., Dev. Ther. 2018, 12, 3343.
S. Ghassemi, S. Nunez-Cruz, R. S. O'Connor, J. A. Fraietta, P. R. Patel, J. Scholler, D. M. Barrett, S. M. Lundh, M. M. Davis, F. Bedoya, Cancer Immunol. Res. 2018, 6, 1100.
B. Philip, E. Kokalaki, L. Mekkaoui, S. Thomas, K. Straathof, B. Flutter, V. Marin, T. Marafioti, R. Chakraverty, D. Linch, Blood 2014, 124, 1277.
A. W. Nienow, in Mixing in the Process Industries, 2nd ed. (Eds: N. Harnby, M. Edwards, A. Nienow), Butterworth Heinemann, London 1997, p. 364.

Auteurs

Elena Costariol (E)

Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, London, WC1E 6BT, UK.

Marco C Rotondi (MC)

Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, London, WC1E 6BT, UK.

Arman Amini (A)

Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, London, WC1E 6BT, UK.

Christopher J Hewitt (CJ)

Aston Medical Research Institute, School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.

Alvin W Nienow (AW)

Aston Medical Research Institute, School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.
School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

Thomas R J Heathman (TRJ)

Hitachi Chemical Advanced Therapeutic Solutions (HCATS), 4 Pearl Court, Allendale, NJ, 07401, USA.

Qasim A Rafiq (QA)

Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, London, WC1E 6BT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH